CDKN2B-AS1 and coronary artery disorder: Recent clinical studies have provided further support to the atheroprotective role of circular ANRIL, but the conclusive understanding of ANRIL's expression patterns in different stages of CAD is still lacking (Razeghian‐Jahromi et al., 2022; Rodríguez‐Esparragón et al., 2023).